Affinity DataKi: 0nMAssay Description:Inhibitory activity against dihydrofolate reductase (DHFR) of L-1210 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 0nMAssay Description:Inhibitory activity against dihydrofolate reductase (DHFR) of L-1210 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 0.00200nMAssay Description:Inhibitory activity against dihydrofolate reductase (DHFR) of L-1210 cellsMore data for this Ligand-Target Pair
Affinity DataKi: >0.00400nMAssay Description:Inhibitory activity against dihydrofolate reductase (DHFR) of L-1210 cellsMore data for this Ligand-Target Pair
Affinity DataKi: >0.00400nMAssay Description:Inhibitory activity against dihydrofolate reductase (DHFR) of L-1210 cellsMore data for this Ligand-Target Pair
Affinity DataKi: >0.00400nMAssay Description:Inhibitory activity against dihydrofolate reductase (DHFR) of L-1210 cellsMore data for this Ligand-Target Pair
Affinity DataKi: >0.00400nMAssay Description:Inhibitory activity against dihydrofolate reductase (DHFR) of L-1210 cellsMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 54nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 63nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 116nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 226nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: <1.00E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: <1.00E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 2.97E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 5.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 5.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: 5.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
TargetDNA topoisomerase 2-alpha/2-beta(Homo sapiens (Human))
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Sloan-Kettering Institute For Cancer Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair